H.C. Wainwright increased its price target on Corcept Therapeutics (NASDAQ:CORT) shares to $115 from the previous $80, while ...
Bind Research launched to transform disordered proteins into effective drug targetsUK’s first not-for-profit Focused Research Organisation ...
The urgent need for a transition to sustainable energy sources demands a significant acceleration of traditional research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback